Subscribe
Low awareness of RSV in adults and misperceptions about the goal of vaccination aren't new challenges, says Kelly Moore, MD, MPH, Immunize.org president and CEO.
GSK Adult RSV Vaccine: Expert Highlights Path to FDA Approval
GSK Adult RSV Vaxx: Public Health Expert Reviews Topics for ACIP Meeting in June
First RSV Vaccine Brings "Sense of Relief" to Public Health Experts, Says Immunize.org President
Study Finds COVID-19 Neutralizing Antibody Response Differs by Vaccine Type
Ghassan Abou-Alfa, MD, MBA; Riad Salem, MD, MBA; Rachna Shroff, MD, MS, FASCO; Arndt Vogel, MD, PhD
Ruta D. Rao, MD; Kamel Abou Hussein, MD; Jame Abraham MD, FACP; Paolo Tarantino, MD, PhD
Hope S. Rugo, MD, FASCO; Neil M. Iyengar, MD; Heather McArthur, MD, MPH; Jason Aboudi Mouabbi, MD
Gabriela Hobbs, MD; Rami Komrokji, MD; Douglas A. Tremblay, MD
Cindy Neunert, MD, MSCS; Hanny Al-Samkari, MD; Joseph Shatzel, MD, MCR
C. Ola Landgren, MD, PhD; Mohamad Mohty, MD, PhD; Surbhi Sidana, MD
Amrita Krishnan, MD; Meletios Athanasios (Thanos) C. Dimopoulos, MD; Shaji Kumar, MD; Katja Weisel, MD